MARC details
| 000 -LEADER |
|---|
| fixed length control field |
03089cam a22003734i 4500 |
| 001 - CONTROL NUMBER |
|---|
| control field |
18237109 |
| 005 - DATE AND TIME OF LATEST TRANSACTION |
|---|
| control field |
20190508121547.0 |
| 008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION |
|---|
| fixed length control field |
140722s2013 stka b 001 0 eng |
| 010 ## - LIBRARY OF CONGRESS CONTROL NUMBER |
|---|
| LC control number |
2014412477 |
| 020 ## - INTERNATIONAL STANDARD BOOK NUMBER |
|---|
| International Standard Book Number |
9781437720037 (pbk) |
| 020 ## - INTERNATIONAL STANDARD BOOK NUMBER |
|---|
| Cancelled/invalid ISBN |
9781455738014 (eBook) |
| 040 ## - CATALOGING SOURCE |
|---|
| Original cataloging agency |
DLC |
| Language of cataloging |
eng |
| Description conventions |
rda |
| Transcribing agency |
DLC |
| 042 ## - AUTHENTICATION CODE |
|---|
| Authentication code |
pcc |
| 050 00 - LIBRARY OF CONGRESS CALL NUMBER |
|---|
| Classification number |
RL801 |
| Item number |
.C66 2013 |
| 082 00 - DEWEY DECIMAL CLASSIFICATION NUMBER |
|---|
| Classification number |
616.5061 |
| Edition number |
22 |
| Item number |
C |
| 245 00 - TITLE STATEMENT |
|---|
| Title |
Comprehensive dermatologic drug therapy / |
| Statement of responsibility, etc |
[edited by] Stephen E. Wolverton, MD, Theordore Arlook Professor of Clinical Dermatology, Department of Dermatology, Indiana University School of Medicine, Chief of Dermatology, Roudebush, VA Medical Center, Indianapolis, IN, USA. |
| 250 ## - EDITION STATEMENT |
|---|
| Edition statement |
3rd ed. |
| 260 ## - PUBLICATION, DISTRIBUTION, ETC. (IMPRINT) |
|---|
| Place of publication, distribution, etc |
Edinburgh : |
| Name of publisher, distributor, etc |
Saunders/Elsevier, |
| Date of publication, distribution, etc |
c2013. |
| 300 ## - PHYSICAL DESCRIPTION |
|---|
| Extent |
xxii, 826 p. : |
| Other physical details |
ill. ; |
| Dimensions |
28 cm |
| 336 ## - CONTENT TYPE |
|---|
| Content type term |
text |
| Content type code |
txt |
| Source |
rdacontent |
| 337 ## - MEDIA TYPE |
|---|
| Media type term |
unmediated |
| Media type code |
n |
| Source |
rdamedia |
| 338 ## - CARRIER TYPE |
|---|
| Carrier type term |
volume |
| Carrier type code |
nc |
| Source |
rdacarrier |
| 504 ## - BIBLIOGRAPHY, ETC. NOTE |
|---|
| Bibliography, etc |
Includes bibliographical references and index. |
| 505 #0 - FORMATTED CONTENTS NOTE |
|---|
| Formatted contents note |
pt. I. Introduction --<br/>pt. II. Important drug regulatory issues --<br/>pt. III. Systemic drugs for infectious diseases --<br/>pt. IV. Systemic immunomodulatory and intiproliferative drugs --<br/>pt. V. Drugs used in conjunction with ultraviolet or visible light --<br/>pt. VI. Biological therapeutics --<br/>pt. VII. Miscellaneous systemic drugs --<br/>pt. VIII. Topical drugs for infectious diseases --<br/>pt. IX. Topical immunomodulatory and antiproliferative drugs --<br/>pt. X. Miscellaneous topical drugs --<br/>pt. XI. Injectable and mucosal routes of drug administration --<br/>pt. XII. Major adverse effects from systemic drugs --<br/>pt. XIII. Special pharmacology and therapeutic topics. |
| 520 ## - SUMMARY, ETC. |
|---|
| Summary, etc |
Safely and effectively treat a full range of skin disorders with Comprehensive Dermatologic Drug Therapy, 3rd Edition! This trusted dermatology reference provides concise, complete, up-to-date guidance on today's full spectrum of topical, intralesional, and systemic drugs. Dr. Steven E. Wolverton and a team of leading international experts clearly explain what drugs to use, when to use them, and what to watch out for. Prescribe with confidence thanks to quick-access summaries of indications/contraindications, dosage guidelines, drug interactions, drug monitoring guidelines, adverse effects, and treatment protocols. Assess your knowledge and prepare for certification or recertification with more than 800 review questions and answers throughout the book. Contain costs and meet patient expectations with purchase information provided for major drugs. Quickly evaluate drug options for each disease discussed using a highly detailed, disease-specific index. |
| 650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM |
|---|
| Topical term or geographic name as entry element |
Dermatopharmacology. |
| 650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM |
|---|
| Topical term or geographic name as entry element |
Skin Diseases |
| General subdivision |
drug therapy. |
| 650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM |
|---|
| Topical term or geographic name as entry element |
Dermatologic Agents |
| General subdivision |
therapeutic use. |
| 700 1# - ADDED ENTRY--PERSONAL NAME |
|---|
| Personal name |
Wolverton, Stephen E., |
| Relator term |
editor. |
| 856 ## - ELECTRONIC LOCATION AND ACCESS |
|---|
| Materials specified |
Abstract |
| Uniform Resource Identifier |
<a href="http://repository.fue.edu.eg/xmlui/handle/123456789/1779">http://repository.fue.edu.eg/xmlui/handle/123456789/1779</a> |
| 906 ## - LOCAL DATA ELEMENT F, LDF (RLIN) |
|---|
| a |
7 |
| b |
cbc |
| c |
origcop |
| d |
2 |
| e |
ncip |
| f |
20 |
| g |
y-gencatlg |
| 942 ## - ADDED ENTRY ELEMENTS (KOHA) |
|---|
| Source of classification or shelving scheme |
Dewey Decimal Classification |
| Koha item type |
Books |